On Thursday, Martin Shkreli, the pharma bro who jacked up the price of a potentially life-saving drug percent, testified before the Congressional House Oversight Committee. Before doing so Shkreli boasted "I would love to talk to Congress. I would berate them. I would insult them." Shkreli got his change and totally clammed up. For each... Continue Reading →